Clinical Trial Update: The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

View source ↗

Summary

A clinical trial update describes developing an 18F-G1 PET/CT tracer targeting Granzyme B for pan-cancer immunotherapy, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• 18F-G1 PET/CT tracer (18F-G1)

Snippet

Sponsor: Peking University First Hospital | Conditions: Solid Tumors and Hematological Tumors | Status: NOT_YET_RECRUITING